愛玩股
English
基本資料
相對強度
財報分析
成長能力
財務比率
現金流量
償債能力
成本分析
實用連結
雅虎財經
公司簡介
研究報告
在外流通股數
歷史市銷率
歷史本益比
盈餘估計修正
存貨周轉率
應收帳款周轉率
內部人交易
新聞
CYAD Stock
Price - Celyad Oncology SA - MarketWatch
Key Data · Open €0.32 · Day Range 0.32 - 0.32 · 52 Week Range 0.30 - 1.28 · Market Cap €13.05M · Shares Outstanding 26.52M · Public Float 38.92M · Beta N/A ...
CYAD
: Celyad Oncology SA
Stock
Price Quote - EN Brussels
Stock
analysis for Celyad Oncology SA (
CYAD
:EN Brussels) including
stock
price,
stock
chart, company news, key statistics, fundamentals and company profile.
CYAD
| Celyad Oncology S.A.
Stock
Price & News - WSJ
Key
Stock
Data · P/E Ratio (TTM). N/A · EPS (TTM).
€
-0.33 · Market Cap.
€
13.67 M · Shares Outstanding. 26.52 M · Public Float. 38.92 M · Yield.
CYAD
is not ...
CYAD
: Celyad Oncology SA -
Stock
Price, Quote and News
Get Celyad Oncology SA (
CYAD
:Euronext Brussels) real-time
stock
quotes, news, price and financial information from CNBC.
CELYAD ONCOLOGY | BE0974260896 - Euronext Live Markets
Stock
CELYAD ONCOLOGY Common
Stock
BE0974260896 XBRU Euronext Brussels Live Euronext quotes, realtime prices, charts and regulated news.
CYAD
| Celyad Oncology S.A.
Stock
Overview (Belgium
Volume, 24.49K. Market Value, €13.05M. Shares Outstanding, 26.52M. EPS (TTM), -€0.33. P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A.
Celyad Oncology SA (
CYAD
.BR) 株価、見積もり - Stock Events
Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell ...
Celyad Oncology SA (
CYAD
)
Stock
Price - MarketScreener
Celyad Oncology SA (
CYAD
.EBR):
Stock
quote,
stock
chart, quotes, analysis, advice, financials and news for
Stock
Celyad Oncology SA | Euronext Bruxelles: ...
CELYAD ONCOLOGY SA (EBR:
CYAD
)
Stock
Chart | (Apr 2024)
CYAD
— Celyad Oncology SA
Stock
Chart. €0.340.000.00%. be flag icon Last trade - 00:00. HealthcareHighly SpeculativeMicro CapSucker
Stock
· Market Cap. €14.07m.
免責聲明
本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。